Skip to main content
Dwight Im, MD, Obstetrics & Gynecology, Baltimore, MD, Anne Arundel Medical Center

DwightDImMD

Obstetrics & Gynecology Baltimore, MD

Gynecologic Oncology

Clinical Assistant Professor, Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine

Dr. Im is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Im's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Gynecologic Oncology, 1993 - 1995
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Obstetrics and Gynecology, 1989 - 1995
  • Rutgers Robert Wood Johnson Medical School
    Rutgers Robert Wood Johnson Medical SchoolClass of 1989

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1992 - 2024
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Press Mentions

  • Renowned Gynecologic Oncologist and Robotic Surgeon Dr. Dwight Im of Mercy Medical Center Named a Castle Connolly “Top Doctor” for 8th Time
    Renowned Gynecologic Oncologist and Robotic Surgeon Dr. Dwight Im of Mercy Medical Center Named a Castle Connolly “Top Doctor” for 8th TimeAugust 10th, 2021
  • Updated Overall Survival Data and Biomarker Results from Sintilimab ORIENT-11 Study in First-Line Nonsquamous Non-Small Cell Lung Cancer Published in the Journal of Thoracic Oncology
    Updated Overall Survival Data and Biomarker Results from Sintilimab ORIENT-11 Study in First-Line Nonsquamous Non-Small Cell Lung Cancer Published in the Journal of Thoracic OncologyAugust 5th, 2021

Professional Memberships

Hospital Affiliations